$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Dec 1, 2025)
$2.69B
Market Cap
59.17
P/E Ratio
0.36
EPS
$35.72
52 Week High
$16.10
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Apellis Pharmaceuticals, Inc. is an innovative clinical-stage biopharmaceutical company located in Waltham, Massachusetts, specializing in the development of groundbreaking therapies that target the complement system for the treatment of autoimmune and inflammatory diseases. With a robust pipeline, including its flagship investigational asset, the company aims to transform treatment paradigms for patients suffering from complex conditions marked by unmet medical needs. Committed to advancing the science of complement inhibition, Apellis is poised to play a pivotal role in reshaping the biopharmaceutical landscape and delivering impactful solutions to healthcare challenges.
LPTX
HBI
NVDA
TLRY
IPG
BITF
IVP
ASST
ADAP
PLUG
AAL
INTC
NIO
NFE
TSLA
IRBT
BYND
CLSK
MARA
SNAP
F
MTSR
PFE
SOFI
MSTR
CAN
GRAB
BTBT
IBRX
CIFR
IREN
HOOD
AMD
DNN
PLTR
GOOGL
SMR
AG
RIG
T
PLTD
AMC
VHAI
WULF
ITUB
DVLT
RGTI
CPNG
SAND
HL
SHOT
ZAPP
HBAN
CMG
BAC
CDE
NOK
APLD
LPTX
HBI
NVDA
TLRY
IPG
BITF
IVP
ASST
ADAP
PLUG
AAL
INTC
NIO
NFE
TSLA
IRBT
BYND
CLSK
MARA
SNAP
F
MTSR
PFE
SOFI
MSTR
CAN
GRAB
BTBT
IBRX
CIFR
IREN
HOOD
AMD
DNN
PLTR
GOOGL
SMR
AG
RIG
T
PLTD
AMC
VHAI
WULF
ITUB
DVLT
RGTI
CPNG
SAND
HL
SHOT
ZAPP
HBAN
CMG
BAC
CDE
NOK
APLD